The Medical Capital’s biomedical industry has grown from 300 companies in 2002 to more than 700 companies today. The strength of the region’s biomedical industry can be seen not only in its breadth but also in its clusters. Strengths in imaging, orthopedic, neurostimulation, and cardiovascular are most prominent. Newer sectors including biomaterials, health IT, biosensors, and regenerative medicine have also attracted the attention of investors and industry observers.